You are here

Eli Lilly

Trial finds Lilly’s Olumiant could treat type 1 diabetes

Pharmaphorum

Thu, 12/7/23 - 11:00 am

type 1 diabetes

Eli Lilly's obesity drug now available in U.S. pharmacies

Reuters

Tue, 12/5/23 - 09:53 am

Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor

BioSpace

Mon, 12/4/23 - 09:41 am

small lymphocytic leukemia

US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy

Reuters

Sun, 12/3/23 - 09:29 pm

Lilly Puts Potential $660M on the Line for Protein-Protein Interaction Blockers

BioSpace

Wed, 11/29/23 - 11:49 am

small molecule inhibitors

Teva drops patent case against Lilly after two Ajovy patents deemed invalid

Fierce Pharma

Tue, 11/28/23 - 11:40 pm

Teva Pharmaceutical

Eli Lilly supports Alto Neuroscience in $45m Series C round

Clinical Trials Arena

Wed, 11/22/23 - 11:30 am

Alto Neuroscience

psychiatric diesase

The Next Generation of Weight Loss Drugs is Rapidly Approaching

BioSpace

Mon, 11/20/23 - 11:32 am

Manufacturer Lonza says it will not fill obesity drug syringes

Reuters

Fri, 11/17/23 - 10:02 am

drug manufacturing

Why Eli Lilly Stock Flopped While the Market Popped Today

Motley Fool

Wed, 11/15/23 - 11:47 pm

drug manufacturing

Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity

https://bit.ly/49zNkYL

Wed, 11/15/23 - 12:04 pm

clinical trials

Lilly, UCB-Backed ViaNautis Scores $25M for Genetic Nanomedicines

BioSpace

Mon, 11/13/23 - 11:58 am

genetic nanomedicine

AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year

Pharmaphorum

Mon, 11/13/23 - 10:03 am

cardiovascular disease

Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started

Motley Fool

Sun, 11/12/23 - 09:21 pm

Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.

Motley Fool

Fri, 11/10/23 - 12:19 pm

How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets

Medical Marketing and Media

Thu, 11/9/23 - 11:41 pm

FDA Approves Eli Lilly’s Zepbound for Chronic Weight Management

BioSpace

Wed, 11/8/23 - 10:05 pm

An obesity drug biotech gets buy-in from Eli Lilly, venture firms

BioPharma Dive

Tue, 11/7/23 - 09:50 am

Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up

BioSpace

Sun, 11/5/23 - 11:12 pm

Eli Lilly Just Added Another Potential Billion-Dollar Product

Motley Fool

Sun, 11/5/23 - 11:08 pm

ulcerative colitis

Pages